Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
8%
Ph phase_2
1
8%
Ph phase_3
1
8%
Ph not_applicable
8
62%
Ph phase_4
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(7)
Other(5)

Detailed Status

Completed7
unknown5
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 31 (8.3%)
Phase 41 (8.3%)
N/A8 (66.7%)

Trials by Status

unknown538%
completed754%
recruiting18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
PROCEDURE
Total Trials
13